Pregnancy and Neonatal Outcomes Following Prenatal Exposure to Dolutegravir
Journal of Acquired Immune Deficiency Syndromes - United States
doi 10.1097/qai.0000000000002035
Full Text
Open PDFAbstract
Available in full text
Date
August 1, 2019
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)